Your browser doesn't support javascript.
loading
An International, Multicenter Evaluation of Comprehensive Medication Management by Pharmacists in ICU Recovery Centers.
Stollings, Joanna L; Poyant, Janelle O; Groth, Christine M; Rappaport, Stephen H; Kruer, Rachel M; Miller, Emily; Whitten, Jessica A; Mcintire, Allyson M; McDaniel, Cara M; Betthauser, Kevin D; Mohammad, Rima A; Kenes, Michael T; Korona, Rebecca Bookstavar; Barber, Alexandra E; MacTavish, Pamela; Dixit, Deepali; Yeung, Siu Yan A.
Afiliação
  • Stollings JL; Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Poyant JO; Critical Illness, Brain Dysfunction, and Survivorship (CIBS) Center, Nashville, TN, USA.
  • Groth CM; Department of Pharmacy, Tufts Medical Center, Boston, MA, USA.
  • Rappaport SH; Department of Pharmacy, University of Rochester Medical Center, Rochester, NY, USA.
  • Kruer RM; Department of Pharmacy, University of Rochester Medical Center, Rochester, NY, USA.
  • Miller E; Department of Pharmacy, Indiana University Health, Adult Academic Health Center, Indianapolis, IN, USA.
  • Whitten JA; Department of Pharmacy, Indiana University Health, Adult Academic Health Center, Indianapolis, IN, USA.
  • Mcintire AM; Department of Pharmacy, Eskenazi Health, Indianapolis, IN, USA.
  • McDaniel CM; Department of Pharmacy, Eskenazi Health, Indianapolis, IN, USA.
  • Betthauser KD; Department of Pharmacy, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
  • Mohammad RA; Department of Pharmacy Services, Barnes-Jewish Hospital, St. Louis, MO, USA.
  • Kenes MT; Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA.
  • Korona RB; Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA.
  • Barber AE; Department of Pharmacy, Atrium Health Wake Forest Baptist, Winston-Salem, NC, USA.
  • MacTavish P; Department of Pharmacy, Atrium Health Wake Forest Baptist, Winston-Salem, NC, USA.
  • Dixit D; Pharmacy Department, Glasgow Royal Infirmary, Glasgow, Scotland.
  • Yeung SYA; Ernest Mario School of Pharmacy, Rutgers University, New Brunswick, NJ, USA.
J Intensive Care Med ; 38(10): 957-965, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37198935
ABSTRACT

BACKGROUND:

Post-intensive care syndrome (PICS) is defined as a new or worsening impairment in physical, cognitive, or mental health following critical illness. Intensive care unit recovery centers (ICU-RC) are one means to treat patients who have PICS. The purpose of this study is to describe the role of pharmacists in ICU-RCs. RESEARCH QUESTION What is the number and type of medication interventions made by a pharmacist at an ICU-RC at 12 different centers? STUDY DESIGN AND

METHODS:

This prospective, observational study was conducted in 12 intensive care units (ICUs)/ICU-RCs between September 2019 and July 2021. A full medication review was conducted by a pharmacist on patients seen at the ICU-RC.

RESULTS:

507 patients were referred to the ICU-RC. Of these patients, 474 attended the ICU-RC and 472 had a full medication review performed by a pharmacist. Baseline demographic and hospital course data were obtained from the electronic health record and at the ICU-RC appointment. Pharmacy interventions were made in 397 (84%) patients. The median number of pharmacy interventions per patient was 2 (interquartile range [IQR] = 1,3). Medications were stopped and started in 124 (26%) and 91 (19%) patients, respectively. The number of patients that had a dose decreased and a dose increased was 51 (11%) and 43 (9%), respectively. There was no difference in the median total number of medications that the patient was prescribed at the start and end of the patient visit (10, IQR = 5, 15). Adverse drug event (ADE) preventive measures were implemented in 115 (24%) patients. ADE events were identified in 69 (15%) patients. Medication interactions were identified in 30 (6%) patients.

INTERPRETATION:

A pharmacist plays an integral role in an ICU-RC resulting in the identification, prevention, and treatment of medication-related problems. This paper should serve as a call to action on the importance of the inclusion of a pharmacist in ICU-RC clinics.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacêuticos / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos Tipo de estudo: Clinical_trials / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacêuticos / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos Tipo de estudo: Clinical_trials / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article